Clinical Trial Update: Therapy Optimization in Multiple Sclerosis (MS)

View source ↗

Summary

This document provides an update on a completed clinical trial evaluating therapy optimization for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Teva Neuroscience, Inc. | Conditions: Multiple Sclerosis | Status: COMPLETED